Cefoxitin
- Product NDC
- 63323-341
- 11-digit product format
- 633230341
- Labeler code
- 63323
- Product ID
- 63323-341_0fffe10d-e5bc-4a0c-ae5b-bbf4095990ba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefoxitin Sodium
- Dosage form
- POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA065414
- Marketing category
- ANDA
- Marketing start
- 2011-07-06
- Substance
- CEFOXITIN SODIUM
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefoxitin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFOXITIN SODIUM | 1 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Q68050H03T |
| Rxcui | 1665102, 1665107 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-341-01 | Cefoxitin | 1 in 1 VIAL | POWDER, FOR SOLUTION | 1 | | 8 |
| 63323-341-25 | Cefoxitin | 25 in 1 CARTON | POWDER, FOR SOLUTION | 25 | | 8 |
| 63323-341-29 | Cefoxitin | 25 in 1 CARTON | POWDER, FOR SOLUTION | 25 | | 6 |
| 63323-341-41 | Cefoxitin | 1 in 1 VIAL | POWDER, FOR SOLUTION | 1 | | 6 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFOXITIN SODIUM | ACTIVE INGREDIENT | Q68050H03T | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| CEFOXITIN | ACTIVE MOIETY | 6OEV9DX57Y | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| CEFOXITIN SODIUM | ACTIVE INGREDIENT | Q68050H03T | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| CEFOXITIN | ACTIVE MOIETY | 6OEV9DX57Y | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-341 | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 8 | Current NDC, Legacy NDC, 2 package rows | 20221004_d02170ff-65aa-48b8-a922-94271c46ffa7.zip |
| 63323-341 | CEFOXITIN (CEFOXITIN SODIUM) POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20230721_2a9d1e7b-96ee-4e6c-a1e8-47b76b924422.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-341-01 | 63323034101 | 1 in 1 VIAL | | | | | | Historical |
| 63323-341-25 | 63323034125 | 25 VIAL in 1 CARTON (63323-341-25) / 1 POWDER, FOR SOLUTION in 1 VIAL (63323-341-01) | 25 vial | 2011-07-06 | 0000-00-00 | No | No | Current |
| 63323-341-29 | 63323034129 | 25 VIAL in 1 CARTON (63323-341-29) / 1 POWDER, FOR SOLUTION in 1 VIAL (63323-341-41) | 25 vial | 2011-07-06 | 0000-00-00 | No | No | Current |
| 63323-341-41 | 63323034141 | 1 in 1 VIAL | | | | | | Historical |